BRIEF-Edwards Lifesciences Reaffirms Strategy For Sustainable, Differentiated Growth At Annual Investor Conference

Reuters12-04

BRIEF-Edwards Lifesciences Reaffirms <a href="https://laohu8.com/S/MSTR">Strategy</a> For Sustainable, Differentiated Growth At Annual Investor Conference

Dec 4 (Reuters) - Edwards Lifesciences Corp EW.N:

EDWARDS LIFESCIENCES REAFFIRMS STRATEGY FOR SUSTAINABLE, DIFFERENTIATED GROWTH AT ANNUAL INVESTOR CONFERENCE
REAFFIRMS 2025 SALES GROWTH GUIDANCE OF 9%-10%
: REAFFIRMING 2025 EPS OUTLOOK OF $2.56 TO $2.62
PROJECTS 2026 SALES GROWTH OF 8%-10%
OUTLOOK FY 2026 ADJUSTED LEVERAGED EPS OF $2.80 - $2.95
FY2025 EARNINGS PER SHARE VIEW $2.58, REVENUE VIEW $6.03 BILLION -- LSEG IBES DATA
FY2026 EARNINGS PER SHARE VIEW $2.85, REVENUE VIEW $6.62 BILLION -- LSEG IBES DATA

Source text: ID:nBw4HJSQNa

Further company coverage: EW.N

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2588877388?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-04 22:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2588877388","market":"us","top_or_hot":-1,"title":"BRIEF-Edwards Lifesciences Reaffirms Strategy For Sustainable, Differentiated Growth At Annual Investor Conference","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Edwards Lifesciences Reaffirms <a href=\"https://laohu8.com/S/MSTR\">Strategy</a> For Sustainable, Differentiated Growth At Annual Investor Conference</title></head><body><p><span>Dec 4 (Reuters)</span><span> - </span>Edwards Lifesciences Corp <span>EW.N</span>:</p><ul><li><p>EDWARDS LIFESCIENCES REAFFIRMS STRATEGY FOR SUSTAINABLE, DIFFERENTIATED GROWTH AT ANNUAL INVESTOR CONFERENCE</p></li><li><p>REAFFIRMS 2025 SALES GROWTH GUIDANCE OF 9%-10%</p></li><li><p>: REAFFIRMING 2025 EPS OUTLOOK OF $2.56 TO $2.62</p></li><li><p>PROJECTS 2026 SALES GROWTH OF 8%-10%</p></li><li><p>OUTLOOK FY 2026 ADJUSTED LEVERAGED EPS OF $2.80 - $2.95</p></li><li><p>FY2025 EARNINGS PER SHARE VIEW $2.58, REVENUE VIEW $6.03 BILLION -- LSEG IBES DATA</p></li><li><p>FY2026 EARNINGS PER SHARE VIEW $2.85, REVENUE VIEW $6.62 BILLION -- LSEG IBES DATA</p></li></ul><p>Source text: <span>ID:nBw4HJSQNa</span></p><p>Further company coverage: <span>EW.N</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Edwards Lifesciences Reaffirms Strategy For Sustainable, Differentiated Growth At Annual Investor Conference</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Edwards Lifesciences Reaffirms Strategy For Sustainable, Differentiated Growth At Annual Investor Conference\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-04 22:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Edwards Lifesciences Reaffirms <a href=\"https://laohu8.com/S/MSTR\">Strategy</a> For Sustainable, Differentiated Growth At Annual Investor Conference</title></head><body><p><span>Dec 4 (Reuters)</span><span> - </span>Edwards Lifesciences Corp <span>EW.N</span>:</p><ul><li><p>EDWARDS LIFESCIENCES REAFFIRMS STRATEGY FOR SUSTAINABLE, DIFFERENTIATED GROWTH AT ANNUAL INVESTOR CONFERENCE</p></li><li><p>REAFFIRMS 2025 SALES GROWTH GUIDANCE OF 9%-10%</p></li><li><p>: REAFFIRMING 2025 EPS OUTLOOK OF $2.56 TO $2.62</p></li><li><p>PROJECTS 2026 SALES GROWTH OF 8%-10%</p></li><li><p>OUTLOOK FY 2026 ADJUSTED LEVERAGED EPS OF $2.80 - $2.95</p></li><li><p>FY2025 EARNINGS PER SHARE VIEW $2.58, REVENUE VIEW $6.03 BILLION -- LSEG IBES DATA</p></li><li><p>FY2026 EARNINGS PER SHARE VIEW $2.85, REVENUE VIEW $6.62 BILLION -- LSEG IBES DATA</p></li></ul><p>Source text: <span>ID:nBw4HJSQNa</span></p><p>Further company coverage: <span>EW.N</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nFWN3XA0D7:1","article_id":"2588877388","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2588877388","pubTimestamp":1764857110,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Edwards Lifesciences Reaffirms Strategy For Sustainable, Differentiated Growth At Annual Investor ConferenceDec 4 (Reuters) - Edwards Lifesciences Corp EW.N:EDWARDS LIFESCIENCES REAFFIRMS STRATE","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","IE00BN0W2V16.EUR":"GUINNESS SUSTAINABLE GLOBAL EQUITY \"C\" (EUR) ACC","BK4585":"ETF&股票定投概念","BK4567":"ESG概念","IE00BN0W2W23.USD":"GUINNESS SUSTAINABLE GLOBAL EQUITY \"C\" (USD) ACC","BK4082":"医疗保健设备","LU0345774631.USD":"NINETY ONE GSF AMERICAN FRANCHISE \"A\" (USD) INC","EW":"爱德华兹","IE00BN0W2T93.GBP":"GUINNESS SUSTAINABLE GLOBAL EQUITY \"C\" (GBP) ACC","IE00BFXG0V08.USD":"BNY MELLON GLOBAL LEADERS \"B\" (USD) ACC","IE00BYQQ9H92.USD":"BNY MELLON GLOBAL LEADERS \"A\" (USD) ACC","BK4504":"桥水持仓","LU0345774391.USD":"NINETY ONE GSF AMERICAN FRANCHISE \"A\" (USD) ACC"},"translate_title":"简介-爱德华兹生命科学公司在年度投资者会议上重申可持续、差异化增长战略","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EW":0.9},"content_text":"BRIEF-Edwards Lifesciences Reaffirms Strategy For Sustainable, Differentiated Growth At Annual Investor ConferenceDec 4 (Reuters) - Edwards Lifesciences Corp EW.N:EDWARDS LIFESCIENCES REAFFIRMS STRATEGY FOR SUSTAINABLE, DIFFERENTIATED GROWTH AT ANNUAL INVESTOR CONFERENCEREAFFIRMS 2025 SALES GROWTH GUIDANCE OF 9%-10%: REAFFIRMING 2025 EPS OUTLOOK OF $2.56 TO $2.62PROJECTS 2026 SALES GROWTH OF 8%-10%OUTLOOK FY 2026 ADJUSTED LEVERAGED EPS OF $2.80 - $2.95FY2025 EARNINGS PER SHARE VIEW $2.58, REVENUE VIEW $6.03 BILLION -- LSEG IBES DATAFY2026 EARNINGS PER SHARE VIEW $2.85, REVENUE VIEW $6.62 BILLION -- LSEG IBES DATASource text: ID:nBw4HJSQNaFurther company coverage: EW.N ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"conferences","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2588877388","isCrawlerRequest":true}